INTRODUCTION
Indeterminate dendritic cell tumor (IDCT) is a rare neoplasm sharing some common features with Langerhans cell histiocytosis with respect to morphology and immunophenotype, but lacking Birbeck granules characteristic of Langerhans cells 1 . IDCT can occur as multiple solid red, yellow, or reddish-brown papulonodules, or, less commonly, as a solitary lesion. The clinical course of IDCT is usually benign, IDCT-related mortality was hardly seen in literature and there is no established treatment protocol to follow 1 . Here, we report a rare case of IDCT which resembled angiosarcoma of the scalp with an aggressive clinical course.
CASE REPORT
A 90-year-old male with a three month history of asymptomatic skin lesions on his scalp attended our dermatology department. Skin examination showed multiple violaceous confluent papules, nodules and plaques with a central haemorrhagic crust on his scalp (Fig. 1) . Moreover, an enlarged preauricle lymph node (1.5×1.5 cm) was noted. The patient was otherwise well. The results of routine laboratory studies were negative or within normal limits. The pathological evaluation revealed hyperkeratosis of the epidermis, with multiple tumor nodules with central necrosis infiltrated in the dermis. The medium-sized tumor cells had abundant eosinophilic cytoplasm. Reniform nuclei and nuclear grooves were occasionally observed. Multinucleate giant cells and eosinophils were absent (Fig.  2) . Immunohistochemical analyses showed that the tumor cells were positive for CD1a, S100, CD31, partially positive for CD68 (PGM1), and negative for Langerin, CD34, FXIIIa, Fli-1, HMB45, A103, EMA and PCK (Fig. 3) . The Ki-67 proliferation index was 35%. A diagnosis of IDCT was made. We thought this patient's lymphadenopathy were no malignant at first. Because IDCT never shows a metastatic feature. So, local electron beam therapy (20 Gy/10 fractions) was initiated to his scalp lesions, and nearly 80% of lesions regressed. Two months later, palpable non-tender nodes developed in the patient's right neck and multiple painless, firm, subcutaneous nodules with poor mobility were found on his scalp, face and neck. Computed tomography scan showed multiple nodules in his bilateral parotid glands region, right carotid sheath region and mediastinum, and enlarged lymph nodes were absent in his abdomen (Fig. 4) . A subsequent intensity modulated radiation therapy was delivered to his neck region and mediastinum with 40 Gy/10 fractions separately. The patient's condition continued to deteriorate and he died due to respiratory and circulatory failure three months later. ETV3-NCOA2 clonal translocations in three IDCT cases, which were absent in the control groups of other types of histiocytosis, a finding that may suggest a particular pathogenesis of IDCT. There is no age or sex predilection in IDCT 1 . The patient in this case is the oldest described in the literature to the best of our knowledge.The location of his skin lesions on the scalp differed from other cases of IDCT, and the lesions were highly reminiscent of scalp angiosarcoma. However, the histological changes did not indicate angiosarcoma, which is characterized by pleomorphic and hyperchromatic endothelial cells and the formation of ill-defined vascular spaces. The distant metastases and subsequent fatal prognosis in this case suggests that IDCT can be aggressive in rare cases. Deng et al. 4 reported an IDCT patient with skin lesions located on the scalp. This patient had a favorable prognosis; although, in this case the lesions had the appearance of melanoma. Vener et al. 5 reported a case of IDCT where the patient developed acute myeloblastic leukemia (AML) after six years of intermittent chemotherapy. However, it is difficult to establish whether the development of AML was associated with IDCT due to the application of chemotherapies and the relatively large time span between the onset of these two diseases.
DISCUSSION
The Ki-67 index of 35%, which was higher than in previously reported cases 6, 7 , might hint at the aggressive clinical course in this case. Rezk et al. 1 reported an IDCT patient with B-cell gene rearrangement who experienced an aggressive clinical course. Although the patient had a history of follicular lymphoma, there was no evidence of the coexistence of these two diseases. Unfortunately, the Ki-67 index was not described. 4 . The most impressive feature of the case reported here was the remarkable progress of the illness, which suggests that some cases of IDCT require aggressive treatment for the benefit of the patient.
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